AnJieMing Medical Secures Tens of Millions in Pre-A Funding Led by Hengqin Venture Capital

Investment Circle (ID: pedaily2012) November 27 News: AGMed Technology Limited (referred to as: "AGMED"") CompletedTens of Millions of RMB in Pre-A Round Financing. This round of financing was led byHengqin Venture CapitalLeading investment,Shanghai RongwangAnd other strategic industry capital follow-up investments, existing shareholdersYuanming CapitalContinuous support.

This round of financing has provided important financial support for AGMED's development, and will mainly be used to accelerate the clinical trials and registration applications of innovative medical devices —— Continuous Intraocular Pressure Monitoring System, marketization of the corneal analysis system, as well as the expansion and upgrading of the team.

AGMed Technology Limited was established on October 13, 2021, as an innovative medical technology company specializing in the ophthalmology field. Starting with early glaucoma diagnostic equipment, the company is developing integrated, full-cycle diagnosis and treatment solutions. It is committed to providing patients with safe, efficient, and precise medical devices while contributing to the visual health of a broader population in China. AGMed collaborates with multiple research institutions and hospitals, including the Hong Kong University of Science and Technology, Zhongshan Ophthalmic Center of Sun Yat-sen University, and Shenzhen People's Hospital, to jointly advance world-leading technology research and achieve breakthroughs in high-end ophthalmic diagnostic and treatment equipment and systems produced in China.